- Herna Verhagen and Sanjay Poonen proposed as new members of Philips’ Supervisory Board
- Paul Stoffels and Marc Harrison proposed for re–appointment as members of the Supervisory Board
- Neelam Dhawan to retire from the Supervisory Board after third consecutive term
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that its Supervisory Board will propose the appointments of Mrs. Herna Verhagen and Mr. Sanjay Poonen as new members of the Supervisory Board at the Annual General Meeting of Shareholders (AGM), which will be held on May 10, 2022. Furthermore, Dr. Paul Stoffels and Dr. Marc Harrison, whose first terms expire in 2022, will be proposed for re-appointment as members of the Supervisory Board. Mrs. Neelam Dhawan, who joined Philips’ Supervisory Board in 2012, will retire from the Board after her third consecutive term, effective upon closing of the 2022 AGM.
“We are very pleased to nominate Mrs. Herna Verhagen and Mr. Sanjay Poonen as new members of Philips’ Supervisory Board, supporting the company to deliver on its purpose of improving people’s health and well-being through innovation,” said Feike Sijbesma, Chairman of the Supervisory Board of Royal Philips. “With her proven track record in driving a customer-first company culture and a background in e-commerce logistics, Mrs. Verhagen will bring valued and new perspectives to the Supervisory Board, while Mr. Poonen’s extensive experience in enterprise IT will further strengthen the Supervisory Board’s digital competencies.”
“We are also very pleased that Dr. Paul Stoffels, the current Vice Chair, and Dr. Marc Harrison remain available as members of the Board,” added Mr. Sijbesma. “Their expertise and experience in healthcare innovation is extremely valuable as Philips aims to support the transformation of healthcare with new health technology solutions along the health continuum.”
“On behalf of the Executive Committee and the Supervisory Board, I would like to express my deep gratitude to Neelam Dhawan for her long-term counsel and support since 2012,” said Frans van Houten, CEO of Royal Philips. “Her in-depth knowledge of the IT industry, including research, software engineering, and services has been indispensable during Philips’ transformation into a health technology leader. We look forward to continue to grow Philips, supported by a diverse and experienced Supervisory Board, aiming to support consumers to lead a healthy life and our healthcare customers achieve the Quadruple Aim of better health outcomes, improved patient and staff experiences, and lower cost of care.”
Mrs. Verhagen (Dutch, 1966) has been CEO and Chair of the Board of Management of PostNL since 2012. Under her leadership, PostNL executed a strategic transformation from a mail delivery company into a growing postal and e-commerce logistic solutions provider. Prior to her role as CEO, Mrs. Verhagen served as a member of the Management Board of PostNL, and was Managing Director Parcels and International PostNL.
Mr. Poonen (American, 1969) has held various executive leadership positions in the software industry, including most recently as Chief Operating Officer for cloud computing company VMware. In this role he was responsible for all business functions, including sales, services, support, marketing and alliances including strategic agreements with Amazon, Microsoft and Google. Prior to VMware, he was President at SAP, where he led analytics, data management and vertical industry solutions.
Subject to AGM approval, Mrs. Verhagen and Mr. Poonen will join a diverse and experienced Supervisory Board, consisting of members from Europe, North America and Asia with wide-ranging business experiences, including in the medical technology, healthcare, pharmaceuticals, IT, engineering and consumer goods industries. For more information about Philips’ Supervisory Board, please follow this link.
For further information, please contact:
Philips Global Press Office
Tel.: +31 6 1521 3446
Philips Investor Relations
Tel.: +31 20 59 77055
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.